Prolight Diagnostics accelerates business development activities following positive feedback at congress

Diagnostic system company Prolight Diagnostics is accelerating its business development activities following positive feedback from the AACC congress. It appears in an investor letter.

With our ground-breaking technology comes the opportunity to develop new ultra-sensitive POC tests that are currently only available in specialized laboratories for clinical diagnostics. Given the positive response we received during the AACC, we are now accelerating our business development activities, the company writes. “However, these activities involve the involvement of many stakeholders in each company, which makes the process time-consuming,” says the company’s COO Karl Bullen and continues. “All conversations are governed by mutual non-disclosure agreements (NDA) and therefore I am not allowed to reveal any company names.”.